A phase III clinical trial to evaluate the immunogenicity and safety of freeze-dried human rabies vaccine (Vero cell) developed by Changchun Zhuoyi Biological Co., Ltd. inoculated in a 4-dose procedure (2-1-1)
Age range
10 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Antibody positive conversion rate of experimental groups
Timeframe: 3 months
Antibody positive conversion rate of 4 doses groups
Timeframe: 3 months
Compare the GMT between two experimental groups
Timeframe: 3 months
Geometric Mean Titer (GMT) of 4 doses groups
Timeframe: 3 months
Safety within 30 minutes
Timeframe: 3 months
Safety within 0-7 days
Timeframe: 3 months
Safety within 6 months
Timeframe: 9months